Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation

Published:2009-12 Issue:12 Volume:33 Page:e215-e217
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

von Bonin Malte,Kiani Alexander,Platzbecker Uwe,Schetelig Johannes,Hölig Kristina,Oelschlägel Uta,Thiede Christian,Ehninger Gerhard,Bornhäuser Martin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference14 articles.

1. Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation;Platzbecker;Haematologica,2008

2. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation;Wolff;Bone Marrow Transpl,2002

3. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update;Bethge;Blood Cells Mol Dis,2008

4. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection;Thiede;Bone Marrow Transpl,1999

5. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data;Calandra;Bone Marrow Transpl,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Synthetic, Xeno‐Free Biomimetic Surface for Serum‐Free Expansion of Human Mesenchymal Stromal Cells;Advanced Biosystems;2020-07-23

2. Comparison of the immunomodulatory effect of single MSC batches versus pooled MSC products;Cell and Tissue Banking;2019-12-20

3. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data;Cytotherapy;2019-04

4. The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review;Frontiers in Immunology;2018-09-11

5. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation;Science Translational Medicine;2017-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3